Details of the Drug
General Information of Drug (ID: DMN861Q)
| Drug Name |
AZALINE B
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indication |
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 5 | Molecular Weight (mw) | 1613.3 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 6.2 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 42 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 18 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 22 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||


